selection from articles
about journal

The Praktické lekárnictvo Journal is a peer-reviewed postgraduate publication aimed at the broader pharmaceutical community. It focuses primarily on current issues related to disease prevention and treatment, presented in a way that benefits pharmaceutical practice. The journal covers information about new drugs, updates for pharmaceutical laboratory professionals, overviews of phytotherapy, articles on pharmacology and pharmacoeconomics, as well as tips for the smooth functioning of pharmacies and reports from significant professional events. Practical Pharmacy Journal is published quarterly and is also available in electronic format.

Chairwoman of the Editorial Board: doc. RNDr. Magdaléna Fulmeková, CSc.

Editorial Board in Slovakia:

PhDr. Marta Janegová
PharmDr. Marcel Jusko, PhD.
PharmDr. Lucia Masaryková, PhD.
RNDr. Mária Mušková, PhD.
RNDr. Roman Smieško
PharmDr. Peter Stanko
doc. PharmDr. Tomáš Tesař, PhD., MBA, MPH, MSc. (HTA)

Editorial Board in Czechia: doc. PharmDr. Martin Doležal Ph.D.
RNDr. Olga Hanzlíčková
PharmDr. Martina Lisá, Ph.D.
Mgr. Josef Malý
doc. MUDr. Jiří Nečas, CSc.
doc. PharmDr. Miloslava Rabišková, CSc.
PharmDr. Zbyněk Sklenář, Ph.D.
prof. MUDr. Pavel Trávník, DrSc.
doc. PharmDr. Lenka Tůmová, CSc.
doc. MUDr. Zdeněk Wilhelm, CSc.
PharmDr. Marie Zajícová

SOLEN, s. r. o.

Ambrova 5
831 01 Bratislava

Editor in charge:

Mgr. Andrea Dúbravčíková

Mobile phone no.: +421 910 956 370

phone: +421 2 5413 1381


Marek Popaďák

Mobile phone no.: +421 902 170 347
phone: +421 2 5465 0647

Ján Kopčok


instructions for authors

Manuscript must be submitted in electronic format via email to: and Submission of a printed manuscript is not required.

The Editorial team reserves the right to make minor stylistic adjustments to the text without consulting the author, who will be informed during the proofreading process. The editorial team also reserves the right to reject texts that do not align with the journal's concept or have not been approved through the peer review process. If necessary, the author's consent will be sought to shorten the manuscript. In case of any formal deficiencies, the manuscript will be returned to the author for revision.

The editors team reserve the right to self-manage the inclusion of unsolicited manuscripts that have passed the peer review process. Given the journal's practical focus, manuscripts should be written in a clear manner, emphasizing the practical application of the provided information in clinical practice.

Authors and co-authors are required to familiarize themselves with the rules of publication ethics, available in full on the journal's website. When submitting an article for publication, the main author must send a written declaration to the editorial office stating that the entire authorial collective is aware of the publication ethics rules and that there are no impediments to publishing the article. Legal relationships between the publisher and the author are governed by the provisions of the Copyright Act.

  • Prologue/Editorial - Addressing current topics in the professional field, up to 2 pages.
  • Current Pharmacotherapy - Drug profiles, pharmaceutical groups, adverse effects, case studies, postgraduate education, interactions, counseling... up to 8 standard pages. The focus should be less on diagnosis (comprehensive visual documentation is welcome) and primarily on treatment. We also request the inclusion of Over-the-Counter (OTC) medications and overviews of individual used active pharmaceutical ingredients and preparations (e.g., in tabular form), including recommended dosages for indications.*
  • Clinical Pharmacy and Toxicology - Pharmacists' work at the patient's bedside, dispensing activities, medication records of patients... practice-based information (case studies, pictorial case studies, "how I do it" articles) - comprehensive visual documentation is welcome, up to 8 standard pages.
  • Pharmaceutical Technology
  • Phytotherapy - Overview of phototherapeutic preparations, up to 8 standard pages.
  • Case Studies in Pharmaceutical Practice - Description of specific cases, up to 4 standard pages.
  • New Drugs - Introduction of innovations in the pharmaceutical market, up to 6 standard pages.
  • Drug Profile - Presentation of individual drugs, up to 4 standard pages.
  • Individual Preparation of Medicines - Compounding of medicines in pharmacies, updates on pharmaceutical dosage forms..., up to 6 standard pages.
  • History of Pharmacy
  • Pharmacy - Theoretical aspects of pharmacy.
  • Medical Devices
  • From Professional Events - Reports from professional congresses and symposia, up to 4 standard pages.
  • Information & Comments - Medications and society, psychology of sales, public opinion surveys, perspectives of/on colleagues abroad, pharmacist versus patient, physician, health insurance companies, pharmaceutical companies, legal and legislative aspects...
  • Font: Times New Roman, size 12, line spacing 1.5,
  • The total number of pages depending on the type of contribution.
  • Divide the article into smaller and more readable sections, and use subheadings and simple divisions if necessary. For original articles and case reports, adhere to the required structure described in manuscript requirements.
  • All abbreviations must be explained at their first use.
  • Parenthesis should always be round ().
  • Domesticated foreign expressions should be written either in accordance with the rules of Slovak orthography or in their original Latin form.
  • In the text, clearly indicate references to all graphical representations, tables, or charts, which should be created using MS Word or MS Excel.
  • For all types of contributions (reviews, original articles, and case reports), please ensure that the text adheres to the general rules of formal Slovak language appropriate for professional publications. For instance, when describing a case in a case report, use complete sentences with full verbs, not in a bullet-point or list format as in laboratory test results. Texts intended for review must be grammatically and stylistically correct.
  1. Title of the work - brief, up to 10 words, capturing the essence of the article.
  2. Name of the main author, affiliation, complete address including telephone and email contact, names and affiliations of co-authors, and full names with titles and affiliations for co-authors.
  3. Brief summary of the submitted work in Slovak and English language, and at least 5 keywords in both languages. For the sections For pharmaceutical lab technicians and Medical devices, an English translation is not required.
  4. Text + tables or graphs and images - please send them as separate attachments in the highest possible quality with accurate captions (maximum 5 tables and 5 images, clearly indicate their placement in the text).
  5. Formatting and list of cited literature: Bibliographic references in the text should be numbered in round brackets in the order in which they are cited for the first time (not alphabetically). Subsequent references to the same source should be marked with the same number as the first mention. In the list of references at the end of the text, list up to 3 authors. For more than 3 authors, list the first 3 followed by the abbreviation "et al." When citing authors in the text (e.g., Culine et al. compared...), use the abbreviation "et al." consistently throughout the text and in the list of references. Additionally, provide a reference to the list of references after the cited author's name (e.g., Culine et al. (15) compared...). Avoid references to abstracts, unpublished observations, and personal communications. Prefer current citations (from the last 3 years). The formatting of bibliographic references should adhere to the citation style used in the MEDLINE/PUBMED databases. The editorial board recommends citing Slovak and Czech works that deal with the topic.
  6. Declaration that the article has not been published or offered for publication in any other journal.
  7. Declaration that the author and co-authors are familiar with the rules of publication ethics and that there are no obstacles to publishing the article.
  8. Use domesticated foreign expressions either in accordance with the rules of Slovak orthography or in the original Latin form. Use Slovak or Latin generic drug names, not Czech or English ones.
  9. Portrait photograph of the main author.

For a Journal Article 1. Hohenegger M. Drug induced rhabdomyolysis. Curr Oppin Pharmacol. 2012;12(3):335-339.

For a Monograph 1. Widimský J, Malý J, et al. Akutní plicní embolie a žilní trombóza. Praha, Czech republic: Triton; 2005:381.

For a Book Chapter or Contribution in a Conference Proceedings 1. Hašek T. Dysfunkcia dolných močových ciest. In: Dvoráčik J, et al. Urologie. Bratislava: ISV; 1998:1307-1333.

For an Article in Electronic Form 1. U.S Food and Drug Administration. Statin Drug Safety, Communication [online]. Available from www: < Informatio/Safety Alert)

ne: + 421 910 956 370

  • A portrait photograph of the author (if there are multiple co-authors, only the main author, or the author whose contact will be provided at the end of the article).
  • A statement declaring that the article has not been published or offered for publication in any other journal.
  • A statement confirming that the author and co-authors have familiarized themselves with the publication ethics guidelines (available in full on the journal's website) and that there are no obstacles to the publication of the article.
  • A declaration of any potential conflicts of interest by the author.
publication ethics

The following text expresses standards of ethical behavior of all parties participating in the process of publishing articles in Solen, s.r.o. journals: the author, the editor, the editorial board, the reviewer, the publisher.

The basis for these guidelines is the already existing policy of Elsevier publishing company and The Best Practice Guidlines for Journal Editors issued by the Committee on Publication Ethics (COPE).

Decision-making regarding publishing of articles: The editor of the Solen company journals is responsible for decisions on which of the accepted articles will be published. The final decision on publication lies with the editorial board based on independent, double-blind review reports. The editor acts in compliance with the policy of the editorial board of the journal and with the legislation that comes into effect in the case of libel, copyright infringement, and plagiarism. The editor may consult their decisions with the editorial board or with the reviewers.

Fair play: The editor evaluates the manuscript according to its intellectual content regardless of race, gender, sexual orientation, religious beliefs, ethnical origin, citizenship and nationality, or the authors` philosophies.

Discrecy/secrecy: Neither the editor nor any member of the editorial board is allowed to disclose any information on the received manuscript to anyone else than to the respective author, the reviewer, potential reviewers, other editorial advisors and to the publisher.

Review reports: A double-blind review process helps to increase the scientific quality of the articles and helps the editor in making decisions on inclusion of the article for publication.

The reviewer`s eligibility: The reviewer should notify the editor if they do not feel sufficiently qualified for the article evaluation, and thus excuse themselves from the review process.

Discrecy/secrecy: Every manuscript received for a review must be regarded as a confidential document and must not be shown nor discussed with persons not involved in the publishing process.

Objectivity: Reviews must be carried out objectively. Personal critical statements against the author`s personality are not acceptable. The reviewers are to state their opinions clearly and back them up with relevant arguments.

Disclosure and conflicts of interest: Information or ideas and thoughts attained from the reviews must be regarded as confidential and must not be used for personal benefit. The reviewers should not evaluate a manuscript in which a conflict of interest occurs, rising from competitivness, created in cooperation or other relationship or connections with the author, company, or institutions connected with the article.

Quality of the article: Each article must include detailed information and references that enable the reader to replicate the data. An article based on a research must include an exact record of the presented piece of work as well as an objective discussion of its significance. The condition for publishing clinical research is that the methods used must comply with the ethical principles of the Declaration of Helsinki and are approved by a relevant ethical committee. The same rules must be respected also by a work based on experiments on animals. Improper or knowingly inaccurate statements mean unethical behavior and are not acceptable.

Originality and plagiarism: Only original works and articles, which have not been published anywhere else yet, nor have they been sent for publication to any other journal, are accepted for publication. If the author uses a work or words of any other author, this must be properly cited. If a picture documentation published anywhere else is re-printed, the original source must be cited and a written consent of the owner of the exclusive rights must be properly presented. Any form of plagiarism represents unethical publication behavior and will not be acceptable.

Multiple, redundant or concurrent publication: Generally speaking, the author should not publish a manuscript describing the same research in more than one journal or an original publication. Accepting the same manuscript into more than one journal shows unethical behavior and is not acceptable.

Acknowledgment of sources: Authors should cite those publications that might be significant for determining the nature of the article. Information gained on a personal basis, eg. in a conversation, correspondence, in a discussion with third parties, cannot be used or published without the statement (written consent) of the source.

Authorship of the article: The authorship should only relate to those who significantly contributed to the concept, design, execution, or interpretation of the presented study or article. All those who contributed to the article or study should be cited as co-authors. Those who participated in partial and important aspects of the particular project (research, article) should be cited or recorded as contributors. The author will ensure that all suitable co-authors are included in the article and that they have approved the final version and agreed on its submission for publication.

Conflicts of interest: In their manuscript, the authors must state all the financial or other significant conflicts of interest that could be interpreted as impacting the results or interpretation of the manuscript. All the resources of the financial support must be disclosed.

Fundamental errors in published works: If the author finds a significant error or inaccuracy in their published work, it is their duty to notify the fact to the editor immediately and to become involved in removal or correction of the article.